| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 03/10/2010 | EP1423376B1 Bicyclic compound, production and use thereof |
| 03/10/2010 | CN101664545A Therapies for renal failure using interferon-beta |
| 03/10/2010 | CN101664388A transnasal transport/immunisation with highly adaptable carriers |
| 03/09/2010 | US7674938 Selective beta 3-adrenoceptor stimulants; obesity, diabetes mellitus, hyperlipidemia, pollakiuria, urinary incontinence, intestinal hypermotility; e.g. 4'-{2-[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl ethylamino]ethoxy}-2,3',5'-trimethylbiphenyl-4-carboxylic acid |
| 03/09/2010 | US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution |
| 03/09/2010 | US7674463 Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist |
| 03/09/2010 | CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators |
| 03/04/2010 | WO2010025135A2 Trimeprazine and ethopropazine derivatives for promoting bone growth |
| 03/04/2010 | WO2010024298A1 Potassium channel regulator |
| 03/04/2010 | WO2010024258A1 Ring-fused azole derivative having pi3k-inhibiting activity |
| 03/04/2010 | WO2010024110A1 Oxotetrahydrofuran-2-yl-benzimidazole derivative |
| 03/04/2010 | WO2009152070A3 Intradialytic administration of sodium thiosulfate |
| 03/04/2010 | WO2009148874A3 Gamma-lactam compounds for promoting bone growth |
| 03/04/2010 | WO2009139984A3 Treatment of bladder dysfunction using liposomal botulinum toxin |
| 03/04/2010 | WO2009137428A3 Methods of determining renal function using technetium-99m tricarbonyl-nitrilotriacetic acid |
| 03/04/2010 | WO2009135029A3 Compositions and methods to treat urinary incontinence |
| 03/04/2010 | WO2009114520A9 Compositions for treatment with metallopeptidases, methods of making and using the same |
| 03/04/2010 | US20100056613 Spiroquinone compound and pharmaceutical composition |
| 03/04/2010 | US20100055093 Pan-cell surface receptor-specific therapeutics |
| 03/04/2010 | CA2734981A1 Oxotetrahydrofuran-2-yl-benzimidazole derivative |
| 03/03/2010 | EP2158910A1 Use of neurokinin antagonists in the treatment of urinary incontinence |
| 03/03/2010 | EP2158900A1 Polymeric delivery formulations of leuprolide with improved efficacy |
| 03/03/2010 | EP1386908B1 Amine derivative with potassium channel regulatory function, its preparation and use |
| 03/03/2010 | CN100592916C Chinese medicine composition for treating lithiasis and preparation thereof |
| 03/02/2010 | US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents |
| 03/02/2010 | US7671026 administering to an interstitial cystitis-afflicted subject a pharmaceutically effective amount of a composition comprising an oligopeptide comprising the disclosed amino acid sequence |
| 03/02/2010 | US7670491 Buffered compositions for dialysis |
| 02/25/2010 | WO2010021385A1 Therapeutic agent for anca-related vasculitis |
| 02/25/2010 | WO2010021351A1 Cycloalkylamine derivative |
| 02/25/2010 | WO2010020882A1 New combination of active ingredients containing an alpha-1antagonist and a pde 4 inhibitor |
| 02/25/2010 | WO2010020881A1 New therapeutic use of drotaverine |
| 02/25/2010 | WO2010020363A1 Substituted 5-aminopyrazoles and use thereof |
| 02/25/2010 | WO2010020307A2 Indazole-5-carboxylic acid hydrazide derivatives |
| 02/25/2010 | WO2009148566A3 Development of a c-reactive protein mutant with improved therapeutic benefit in immune thrombocytopenia and lupus nephritis |
| 02/25/2010 | US20100048666 Novel phenylacetic acid derivative |
| 02/25/2010 | US20100048644 Use of composition comprising amlodipine in preparing medicaments for treating a lower urinary tract disorder |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/25/2010 | US20100048556 Quinoxaline derivatives |
| 02/25/2010 | US20100048507 Food/beverage and pharmaceutical composition for oral administration for improvement in acidic urine each comprising fucoidan as active ingredient |
| 02/25/2010 | US20100047809 Pca3, pca3 genes, and methods of use |
| 02/25/2010 | US20100047367 Compounds and methods for their use |
| 02/25/2010 | US20100047363 Nutritional supplement for patients with chronic kidney disease |
| 02/25/2010 | DE102008038222A1 Indazol-5-carbonsäurehydrazid-derivate Indazole-5-carboxylic acid derivatives |
| 02/25/2010 | CA2734870A1 Therapeutic agent for anca-related vasculitis |
| 02/25/2010 | CA2734787A1 Substituted 5-aminopyrazoles and use thereof |
| 02/24/2010 | EP2157092A1 Remedy for diabetes |
| 02/24/2010 | EP2157089A1 The therapeutic uses of imidazol-5-carboxylic acid derivatives |
| 02/24/2010 | EP2157081A1 Indolinones substituted in six locations, their manufacture and their application as medicine |
| 02/24/2010 | EP2156847A1 New combination of active ingredients containing an alpha1-antagonist and a PDE 4 inhibitor. |
| 02/24/2010 | EP2156843A2 Use of low-dose erythropoietin for the treatment of acute or chronic renal insufficiency and for the treatment of wounds |
| 02/24/2010 | EP2156837A1 Crystalline micropowder particles |
| 02/24/2010 | EP2156835A1 New therapeutic use of drotaverine |
| 02/24/2010 | EP2156824A1 Composition of solifenacin or salt thereof for use in solid formulation |
| 02/24/2010 | EP2155217A2 Human umbilical tissue-derived cell compositions for the treatment of incontinence |
| 02/24/2010 | EP2155207A2 N-acetyl mannosamine as a therapeutic agent |
| 02/24/2010 | EP1007084B1 Immunogenic lhrh compositions and methods relating thereto |
| 02/24/2010 | CN101653424A 高药物载荷片剂 High drug load tablets |
| 02/23/2010 | USRE41151 Comprising a modified NSAID, wherein the NSAID is covalently attached either directly or through a linker molecule to a sulfur-containing functional group containing an optionally substituted hydrocarbyl moiety; nonsteroidal anti-inflammatory drugs; side-effect reduction |
| 02/23/2010 | USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
| 02/23/2010 | US7667021 Neutralizing human anti-IGFR antibody |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7666892 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
| 02/23/2010 | US7666873 N-phenyl-(2R,5S)dimethylpiperazine derivative |
| 02/23/2010 | US7666848 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 02/23/2010 | US7666401 Compositions comprising a ligand of Chemerin R |
| 02/18/2010 | WO2010018800A1 Acetyl pyrrolidinyl indole derivative |
| 02/18/2010 | WO2010018484A1 New uses of diisopropylamine derivatives |
| 02/18/2010 | WO2010017598A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | WO2009114826A3 Treatment systems and methods for renal-related diseases |
| 02/18/2010 | US20100041708 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for it's preparation |
| 02/18/2010 | US20100041660 Novel 2-pyridinecarboxamide derivatives |
| 02/18/2010 | US20100041651 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/18/2010 | US20100041072 Process for identifying a ligand that binds to the nep binding site for the smr1 pentapeptide |
| 02/18/2010 | US20100040627 Baff receptor (bcma), an immunoregulatory agent |
| 02/18/2010 | US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 02/18/2010 | CA2733646A1 Acetyl pyrrolidinyl indole derivative |
| 02/18/2010 | CA2733642A1 Anti-il-12/il-23 antibodies |
| 02/17/2010 | EP2153840A1 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin |
| 02/17/2010 | EP2153825A1 Therapeutic formulation for administering tolterodine with controlled release |
| 02/17/2010 | EP2152283A1 Water soluble opuntia extracts for the inhibition of alpha-1-adrenergic receptors |
| 02/17/2010 | EP2152272A2 Novel 2,3-diamino-quinazolinone derivatives and their medical use |
| 02/17/2010 | EP1675603B9 Use of probiotic bacteria in the treatment of infection |
| 02/17/2010 | EP1511737B1 Aryloximes |
| 02/17/2010 | CN100590124C Tricyclic androgen receptor modulator compounds and method |
| 02/17/2010 | CN100589839C Polypeptide and medicament composition containing polypeptide |
| 02/17/2010 | CN100589806C Use of steroid derivatives for the treatment of angiotensin II related disease e.g. cardiovascular and proliferative disorders |
| 02/16/2010 | US7662974 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 02/16/2010 | US7662948 Antisense oligonucleotides against VR1 |
| 02/16/2010 | US7662825 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/16/2010 | US7662799 Powder of amino acids and method for producing the same |
| 02/16/2010 | US7662794 DNA enzyme to inhibit plasminogen activator inhibitor-1 |
| 02/16/2010 | US7662408 Sustained-release preparations |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2450922C Piperidines for use as orexin receptor antagonists |
| 02/16/2010 | CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors |
| 02/16/2010 | CA2440037C Benzimidazole derivatives for modulating the rage receptor |
| 02/16/2010 | CA2402436C Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 02/11/2010 | WO2010017105A1 Urotensin ii receptor antagonists |
| 02/11/2010 | WO2010017089A1 Methods for detecting symmetrical demethylarginine |
| 02/11/2010 | WO2010016554A1 Cyclic amine compound |